News
Controlled Drugs: Reporting Update
By Kirstye- Dispex Tutor Controlled Drugs Reporting System Update From Thursday 1st December, the Controlled drug reporting website www.cdreporting.co.uk will have several notable changes. The website update suggests it will...
Class 4 Medicines Defect Information: Lucis Pharma Ltd, Oxycodone Hydrochloride 10mg/ml oral solution, EL (22)A/49
Source: MHRA / Gov.uk 29.11.22 Lucis Pharma Ltd has informed the MHRA that there is a typographical error with text on the rear side of the outer packaging for Oxycodone...
English surveillance programme for antimicrobial utilisation and resistance (ESPAUR) report
Source: UK Health Security Agency The ESPAUR report includes national data on antibiotic prescribing and resistance, antimicrobial stewardship implementation, and awareness activities. English surveillance programme for antimicrobial utilisation and resistance...
Last Chance to add to your CPD in 2022!
Upcoming Tutorials Controlled Drugs Part 2 Date: 30th November 2022 Time: 1pm – 2pm What attendees will learn By the end of this course you will have achieved an understanding of: Process of...
Dispensary Management Profitability Review
Overview: This involves a visit to your site, you will receive a thorough review of your dispensary by our experienced Consultant, to help identify any causes for profit loss and...
Ocular Lubricants 3 – Carbomer
By Dr Philip Koopowitz Dispex & Hexagon6 Following last month’s article on Ocular Lubricants, we are pleased to provide you with information on the third class of Ocular Lubricants, namely...
PCN Training Funding
3 Steps to Free Training 1. Identify a leadership & management training requirement. 2. Contact your PCN Lead and provide them with our email training@dispex.net, we will invoice your PCN...
The Upcoming DRUM Submission Deadline
Dispex Education – dispexeducation.theskillsnetwork.com Want to make the most of the opportunity and ensure you know your patients are using their prescribed medicines correctly? Then you need to consider whether...
Class 4 Medicines Defect Information: Macarthys Laboratories t/a Martindale Pharma, Venlafaxine XL 300 mg prolonged-release tablets, EL(22)A/47
Source: MHRA / Gov.uk Martindale Pharma has made the MHRA aware that the GTIN in the 2D barcode and the printed variable data represents the branded version of the product...
NHS gives GP teams direct access to tests to speed up cancer diagnosis
Source: NHS England 16th November 2022 Tens of thousands of cancers could be detected sooner each year thanks to a national roll out of fast-track testing, NHS chief executive Amanda...
Hypromellose Update
Since Hypromellose 0.3% has been taken out of Part VIIIA of the Drug Tariff there has been a rush to change patients on to branded Hypromellose. This is going to...
Patient record project will complete this month
Source: Practice Index 2.11.22 The Government hopes to complete the rollout out of its troubled patient record access project this month, Health Secretary Steve Barclay said yesterday. Earlier this week...
